Search by Drug Name or NDC
NDC 70069-0301-25 Succinylcholine Chloride 20 mg/mL Details
Succinylcholine Chloride 20 mg/mL
Succinylcholine Chloride is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Somerset Therapeutics, LLC. The primary component is SUCCINYLCHOLINE CHLORIDE.
Product Information
| NDC | 70069-0301 |
|---|---|
| Product ID | 70069-301_e7e7642e-acaa-4907-aa55-14d509aab194 |
| Associated GPIs | 74100010102005 |
| GCN Sequence Number | 004676 |
| GCN Sequence Number Description | succinylcholine chloride VIAL 20 MG/ML INJECTION |
| HIC3 | S7A |
| HIC3 Description | NEUROMUSCULAR BLOCKING AGENTS |
| GCN | 17992 |
| HICL Sequence Number | 001948 |
| HICL Sequence Number Description | SUCCINYLCHOLINE CHLORIDE |
| Brand/Generic | Generic |
| Proprietary Name | Succinylcholine Chloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Succinylcholine Chloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/mL |
| Substance Name | SUCCINYLCHOLINE CHLORIDE |
| Labeler Name | Somerset Therapeutics, LLC |
| Pharmaceutical Class | Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA211589 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70069-0301-25 (70069030125)
| NDC Package Code | 70069-301-25 |
|---|---|
| Billing NDC | 70069030125 |
| Package | 25 VIAL in 1 CARTON (70069-301-25) / 10 mL in 1 VIAL (70069-301-01) |
| Marketing Start Date | 2020-01-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |